Search Within

Timothy Chan

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (12)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (48)
  2. Department of Medicine (48)
  3. GSK Faculty (48)
  4. Genitourinary Oncology Service (48)
  5. Solid Tumor Oncology Division (48)
  6. Human Oncology and Pathogenesis Program (42)

More Groups

People
  1. Abraham Hakimi (26)
  2. Robert Motzer (25)
  3. Martin Voss (23)
  4. David Solit (19)
  5. Fengshen Kuo (16)
  6. Paul Russo (13)

More People

Years
  1. 2022 (5)
  2. 2021 (8)
  3. 2020 (8)
  4. 2019 (8)
  5. 2018 (5)
  6. 2017 (3)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Clinical Cancer Research (5)
  3. Nature Genetics (4)
  4. Nature Communications (3)
  5. Cancer Discovery (2)
  6. Lancet Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Nature Publishing Group (10)
  3. American Association for Cancer Research (9)
  4. Biomed Central Ltd (3)
  5. American Association for the Advancement of Science (2)
  6. Elsevier Inc. (2)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: An emerging entity with variable clinical course
    Journal Article

    DiNatale, R. G.; Gorelick, A. N.; Makarov, V.; Blum, K. A.; Silagy, A. W.; Freeman, B.; Chowell, D.; Marcon, J.; Mano, R.; Sanchez, A.; more...
    European Urology Focus (2021)

    Fulltext@MSK | Save
  • Pathogenic ATM mutations in cancer and a genetic basis for radiotherapeutic efficacy
    Journal Article

    Pitter, K. L.; Casey, D. L.; Lu, Y. C.; Hannum, M.; Zhang, Z.; Song, X.; Pecorari, I.; McMillan, B.; Ma, J.; Samstein, R. M.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Sarcomatoid renal cell carcinoma: Biology, natural history and management
    Review

    Blum, K. A.; Gupta, S.; Tickoo, S. K.; Chan, T. A.; Russo, P.; Motzer, R. J.; Karam, J. A.; Hakimi, A. A.
    Nature Reviews Urology (2020)

    Fulltext@MSK | Save
  • Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT)
    Meeting Abstract

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Silagy, A. W.; Marker, M.; Reising, A.; Millholland, J.; Chan, T. A. T.; Russo, P.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response
    Journal Article

    Hakimi, A. A.; Attalla, K.; DiNatale, R. G.; Ostrovnaya, I.; Flynn, J.; Blum, K. A.; Ged, Y.; Hoen, D.; Kendall, S. M.; Reznik, E.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression
    Journal Article

    Marcon, J.; DiNatale, R. G.; Sanchez, A.; Kotecha, R. R.; Gupta, S.; Kuo, F.; Makarov, V.; Sandhu, A.; Mano, R.; Silagy, A. W.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Shapnik, N.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and landscape of actionable genomic alterations in renal cell carcinoma
    Meeting Abstract

    Attalla, K.; DiNatale, R. G.; Reznik, E.; Fong, C.; Sanchez-Vega, F.; Silagy, A. W.; Weng, S.; Coleman, J.; Lee, C. H.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save